Position in GILD
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$365,627
-$44,538 QoQ
Shares Held
2,894
-1.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,542
of 2,266 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Obermeyer Wealth Partners holds $14,931,348 across 9 Drug Manufacturers - General names. GILD ranks #9 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
12,201 | $3,098,687 | |
| 2 | ABBV |
AbbVie Inc.
|
10,832 | $2,725,764 | |
| 3 | AZN |
Astrazeneca PLC
|
11,635 | $2,206,228 | |
| 4 | LLY |
ELI LILLY & Co
|
1,757 | $2,107,398 | |
| 5 | AMGN |
Amgen Inc
|
3,986 | $1,443,410 | |
| 6 | PFE |
Pfizer Inc
|
49,336 | $1,188,010 | |
| 7 | MRK |
Merck & Co., Inc.
|
8,359 | $1,074,131 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
12,532 | $722,093 |
All Filings in GILD
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $365,627 | 2,894 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $410,165 | 2,943 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $362,573 | 2,954 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $326,673 | 2,943 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $328,729 | 2,965 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $324,272 | 2,894 | Shares | Sole | 2025-05-06 | |
| 2020-06-30 | $295,141 | 3,836 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $363,707 | 4,865 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||